Skip to content
Axcess News – Lifestyle
Author:
NICOX SA
Nicox Announces NCX 470 NDA Submission in China by Partner Ocumension
August 10, 2026
Nicox’s NCX 470 New Drug Application Submitted in the United States by Kowa, with Associated €3 million Milestone Payment
July 1, 2026
Nicox Announces Positive Pre-submission Regulatory Feedback in China Supporting NDA filing for NCX 470
June 18, 2026
Reminder: Nicox June 2024 Warrants will expire June 19, 2026
June 8, 2026
Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 24, 2026 and appointment of an ad hoc representative
June 3, 2026
WuXi AppTec Delivers Strong Revenue and Profit Growth in Q1 2026
April 27, 2026
Reminder: Last Exercise Day for Nicox June 2024 Warrants is June 19, 2026
April 20, 2026
WuXi AppTec Beat Full-Year Guidance and Achieved Record Performance in 2025
March 23, 2026
Nicox Highlights Positive NCX 470 Phase 3 Data Confirming Therapeutic Profile at the 2026 American Glaucoma Society Annual Meeting
March 5, 2026